Tag #Obesity

Showing 25 to 36 of 217 results

us.cnn.com

🌐 85% Global Worthiness

Aug 7, 16:17

Eli Lilly's Oral GLP-1 Pill Shows Significant Weight Loss in Phase 3 Trial

Eli Lilly announced positive Phase 3 trial results for its oral GLP-1 obesity drug, orforglipron, showing a 12.4% average weight loss in 3,127 obese adults (excluding diabetics) after 72 weeks, with 59.6% losing at least 10% of their body weight and 39.6% losing at least 15%, and fewer cardiovascula...

Eli Lilly's Oral GLP-1 Pill Shows Significant Weight Loss in Phase 3 Trial

Eli Lilly announced positive Phase 3 trial results for its oral GLP-1 obesity drug, orforglipron, showing a 12.4% average weight loss in 3,127 obese adults (excluding diabetics) after 72 weeks, with 59.6% losing at least 10% of their body weight and 39.6% losing at least 15%, and fewer cardiovascula...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of Eli Lilly's orforglipron Phase 3 trial results on obesity treatment?

In a Phase 3 trial, Eli Lilly's orforglipron, a once-daily oral GLP-1 pill, facilitated a 12.4% average weight reduction in obese adults over 72 weeks. This involved 3,127 participants with at least one weight-related health issue, excluding diabetes. The highest dose resulted in 59.6% achieving 10% weight loss and 39.6% achieving 15% weight loss.

elpais.com

🌐 85% Global Worthiness

Aug 7, 10:16

Cardiorespiratory Fitness a Stronger Mortality Predictor Than Body Weight

A study of almost 400,000 people found cardiorespiratory fitness, measured by peak oxygen consumption (VO2), to be a more significant predictor of mortality than body weight; even with excess weight, high VO2 levels correlated with lower mortality risk.

Cardiorespiratory Fitness a Stronger Mortality Predictor Than Body Weight

A study of almost 400,000 people found cardiorespiratory fitness, measured by peak oxygen consumption (VO2), to be a more significant predictor of mortality than body weight; even with excess weight, high VO2 levels correlated with lower mortality risk.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the underlying mechanisms by which cardiorespiratory fitness reduces mortality risk, even in the presence of obesity?

This research challenges the conventional wisdom that weight is the primary determinant of health outcomes. It demonstrates that even individuals with excess weight can significantly reduce their mortality risk through high levels of cardiorespiratory fitness. This suggests that improving fitness, regardless of weight loss, offers substantial health benefits.

pt.euronews.com

🌐 85% Global Worthiness

Aug 6, 10:19

Maternal Genetics Significantly Influences Childhood Obesity Risk

A study of 2600 British families revealed that while both parents' obesity increases a child's risk, the mother's genetics exert a wider influence on the child's BMI, impacting the child's development and health beyond directly inherited genes, highlighting the need for interventions focused on mate...

Maternal Genetics Significantly Influences Childhood Obesity Risk

A study of 2600 British families revealed that while both parents' obesity increases a child's risk, the mother's genetics exert a wider influence on the child's BMI, impacting the child's development and health beyond directly inherited genes, highlighting the need for interventions focused on mate...

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the most significant finding regarding the influence of parental genetics on childhood obesity, and what are its immediate implications for preventative healthcare strategies?

Children of obese parents are more likely to be obese themselves, with the mother's genes playing a particularly significant role in determining children's weight, according to a new study. The study, published in PLOS Genetics, analyzed data from over 2600 British families and found that while both parents' genetics influence a child's BMI, the mother's genetic influence is broader, impacting the child's development and health even beyond genes directly inherited.

dailymail.co.uk

🌐 85% Global Worthiness

Aug 3, 07:12

Unhealthy Diets Fuel Public Health Crisis in Northern England

Research reveals unhealthy diets are causing a public health crisis in Northern England, with higher rates of diabetes, cardiovascular disease, and obesity linked to low consumption of fruits, vegetables, and fiber, alongside a high density of fast-food outlets.

Unhealthy Diets Fuel Public Health Crisis in Northern England

Research reveals unhealthy diets are causing a public health crisis in Northern England, with higher rates of diabetes, cardiovascular disease, and obesity linked to low consumption of fruits, vegetables, and fiber, alongside a high density of fast-food outlets.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do socioeconomic factors contribute to the dietary deficiencies observed in Northern England?

The study reveals a strong correlation between poor diet and increased mortality from preventable diseases in Northern England. Higher rates of deprivation and food insecurity contribute to low weekly food spending, impacting nutritional intake and leading to higher rates of obesity and related illnesses. This disproportionately affects the North, impacting the entire country's healthcare budget.

nbcnews.com

🌐 85% Global Worthiness

Jul 29, 04:12

Liver Cancer Cases Projected to Rise Sharply by 2050

A new report projects a substantial increase in liver cancer cases by 2050, driven by rising obesity and alcohol consumption, despite a projected decrease in viral hepatitis-related cases; 60% of liver cancer cases are potentially preventable.

Liver Cancer Cases Projected to Rise Sharply by 2050

A new report projects a substantial increase in liver cancer cases by 2050, driven by rising obesity and alcohol consumption, despite a projected decrease in viral hepatitis-related cases; 60% of liver cancer cases are potentially preventable.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the leading causes of liver cancer, and how are their contributions projected to change by 2050?

Liver cancer cases are projected to increase from 870,000 in 2022 to 1.52 million in 2050 without intervention. Viral infections, particularly hepatitis B and C, are leading causes, but their contribution is expected to decrease. Conversely, alcohol and obesity-related cases are expected to rise.

foxnews.com

🌐 85% Global Worthiness

Jul 28, 22:14

CVS Caremark's Weight-Loss Drug Switch Stirs Patient Outrage

CVS Caremark dropped Zepbound (tirzepatide) from its preferred drug list on July 1, 2025, replacing it with Wegovy (semaglutide) due to high costs, prompting negative patient reactions and concerns about treatment disruptions. A study showed Zepbound resulted in greater weight loss than Wegovy.

CVS Caremark's Weight-Loss Drug Switch Stirs Patient Outrage

CVS Caremark dropped Zepbound (tirzepatide) from its preferred drug list on July 1, 2025, replacing it with Wegovy (semaglutide) due to high costs, prompting negative patient reactions and concerns about treatment disruptions. A study showed Zepbound resulted in greater weight loss than Wegovy.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate impacts of CVS Caremark's decision to replace Zepbound with Wegovy on patients using the weight loss medication?

On July 1st, 2025, CVS Caremark removed Zepbound (tirzepatide) from its preferred drug list, replacing it with Wegovy (semaglutide) due to rising costs. This change has angered patients who prefer Zepbound, citing concerns about disrupted treatment and potential side effects from switching medications. Many patients have expressed their frustrations on social media.

dailymail.co.uk

🌐 85% Global Worthiness

Aug 7, 07:18

Metformin Linked to Lower Dementia Risk in Overweight and Obese Individuals

A study of half a million overweight and obese individuals revealed that metformin users had a significantly lower risk of developing dementia and death from any cause, with the greatest benefits observed in those with BMIs between 25 and 34.9.

Metformin Linked to Lower Dementia Risk in Overweight and Obese Individuals

A study of half a million overweight and obese individuals revealed that metformin users had a significantly lower risk of developing dementia and death from any cause, with the greatest benefits observed in those with BMIs between 25 and 34.9.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do the findings of this study compare to previous research on metformin's effects on cognitive health?

The study's findings suggest a potential preventive role for metformin against dementia, particularly in obese populations. This is significant because obesity is a known risk factor for dementia, and this research expands on previous studies focused primarily on diabetic populations. The use of real-world data enhances the generalizability of the results.

abcnews.go.com

🌐 85% Global Worthiness

Aug 7, 16:18

Eli Lilly's Oral GLP-1 Pill Shows Significant Weight Loss in Phase 3 Trial

Eli Lilly's Phase 3 trial of the oral GLP-1 drug orforglipron showed an average weight loss of 27.3 pounds (12% body weight) in over 3,100 overweight or obese adults over 72 weeks, with cardiovascular benefits and side effects similar to injectable GLP-1s; the company plans to seek regulatory approv...

Eli Lilly's Oral GLP-1 Pill Shows Significant Weight Loss in Phase 3 Trial

Eli Lilly's Phase 3 trial of the oral GLP-1 drug orforglipron showed an average weight loss of 27.3 pounds (12% body weight) in over 3,100 overweight or obese adults over 72 weeks, with cardiovascular benefits and side effects similar to injectable GLP-1s; the company plans to seek regulatory approv...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the key findings from Eli Lilly's Phase 3 trial on the efficacy and safety of orforglipron in weight loss and cardiovascular health?

Eli Lilly announced that its new oral GLP-1 pill, orforglipron, resulted in an average weight loss of 27.3 pounds over 72 weeks in a Phase 3 trial involving over 3,100 overweight or obese adults. The highest dose (36mg) led to approximately 12% body weight reduction. This offers a potential non-injectable alternative to existing treatments.

chinadaily.com.cn

🌐 85% Global Worthiness

Aug 4, 04:11

Preventable Liver Cancer: A Lancet Report Outlines Global Strategy

A new Lancet report reveals that over 60% of the world's liver cancer cases are preventable; a 2% reduction in the annual incidence rate could prevent 8.8 million new cases and 7.7 million deaths by 2050, highlighting the need for global collaboration.

Preventable Liver Cancer: A Lancet Report Outlines Global Strategy

A new Lancet report reveals that over 60% of the world's liver cancer cases are preventable; a 2% reduction in the annual incidence rate could prevent 8.8 million new cases and 7.7 million deaths by 2050, highlighting the need for global collaboration.

Progress

16% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How are changing lifestyles and metabolic diseases reshaping the global landscape of liver cancer incidence and mortality?

The report highlights a shift in liver cancer causes, with metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH) emerging as major contributors alongside traditional risk factors like hepatitis B and C. Obesity and diabetes are key drivers of this shift, particularly impacting developed nations where alcohol-related cases are also projected to rise.

dailymail.co.uk

🌐 85% Global Worthiness

Jul 30, 04:12

One-Third of Baby Foods Ultra-Processed, Raising Obesity Concerns

A University of Leeds study found that 31% of baby foods are ultra-processed, with some containing up to 89% of calories from sugar, contributing to obesity and other health problems, prompting calls for stricter government regulations.

One-Third of Baby Foods Ultra-Processed, Raising Obesity Concerns

A University of Leeds study found that 31% of baby foods are ultra-processed, with some containing up to 89% of calories from sugar, contributing to obesity and other health problems, prompting calls for stricter government regulations.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What percentage of ready-made baby foods are ultra-processed, and what are the immediate health implications for infants?

A University of Leeds study revealed that 31% of baby foods are ultra-processed (UPF), containing multiple ingredients and additives linked to health issues. Some products derive up to 89% of their calories from sugar, while others marketed as healthy still have high sugar content, potentially harming children's health and contributing to obesity.

elmundo.es

🌐 85% Global Worthiness

Jul 29, 04:12

Preventable Liver Cancer: Obesity and Alcohol Consumption to Surpass Hepatitis as Leading Causes

A Lancet study reveals that over 60% of global liver cancer cases are preventable, with obesity and alcohol consumption projected to surpass hepatitis as leading causes by 2050, necessitating urgent public health interventions to avoid a doubling of new cases within 25 years.

Preventable Liver Cancer: Obesity and Alcohol Consumption to Surpass Hepatitis as Leading Causes

A Lancet study reveals that over 60% of global liver cancer cases are preventable, with obesity and alcohol consumption projected to surpass hepatitis as leading causes by 2050, necessitating urgent public health interventions to avoid a doubling of new cases within 25 years.

Progress

24% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How are the relative contributions of viral hepatitis and obesity-related factors to liver cancer changing, and what are the long-term implications of this shift?

The study highlights the shifting landscape of liver cancer risk. While viral hepatitis remains a significant factor, its impact is decreasing due to improved treatments and vaccinations. Conversely, obesity and alcohol consumption are driving an increase in MASLD-related liver cancer, necessitating public health interventions.

abcnews.go.com

🌐 75% Global Worthiness

Jul 24, 04:12

Weight Regain Follows GLP-1 Medication Discontinuation

A study in BMC Medicine reveals that patients stopping GLP-1 weight-loss drugs like Wegovy and Ozempic regain weight within two months, highlighting the chronic nature of obesity and need for ongoing management, despite continued healthy habits.

Weight Regain Follows GLP-1 Medication Discontinuation

A study in BMC Medicine reveals that patients stopping GLP-1 weight-loss drugs like Wegovy and Ozempic regain weight within two months, highlighting the chronic nature of obesity and need for ongoing management, despite continued healthy habits.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate effects of stopping GLP-1 weight-loss medications, and what does this imply about the long-term management of obesity?

A new study shows that people who discontinue GLP-1 medications like Wegovy and Ozempic for weight loss regain a significant portion of the lost weight within two months. The weight regain often continues for several months before stabilizing. This is consistent with other chronic disease treatments where the medication's effects cease upon discontinuation.

Showing 25 to 36 of 217 results